- Home
- / Aevi Genomic Medicine
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Aevi Genomic Medicine financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
CreditSafe Score
?
Score changed on Jun 12, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 |
|---|---|---|---|---|---|---|---|---|
| General and administrative expense | 4.9M | 7.2M | 10.5M | 10.7M | 13.0M | 13.5M | 9.5M | 8.7M |
| Operating expense total | 10.0M | 12.6M | 19.4M | 21.2M | 31.3M | 41.9M | 34.7M | 8.7M |
| EBIT | (10.0M) | (12.6M) | (17.8M) | (18.9M) | (36.6M) | (41.9M) | (34.7M) | (31.0M) |
| Interest income | 2.1M | 5.0K | 726.0K | 586.0K | 1.0K | 15.0K | 27.0K | 188.0K |
| Interest expense | 49.0K | 20.0K | 68.0K | 1.4M | ||||
| Pre tax profit | (8.1M) | (15.1M) | (17.1M) | (18.4M) | (38.0M) | (41.9M) | (34.7M) | (30.8M) |
| Income tax expense | 3.0K | 19.0K | 17.0K | 12.0K | 17.0K | 16.0K | ||
| Net Income | (8.1M) | (15.1M) | (17.1M) | (18.4M) | (38.0M) | (41.9M) | (34.7M) | (30.8M) |